Moderna Drops 11%, ImmunityBio Slide Wakes Biotech Rout
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Discover various ways to sell products for cash at home. Turn your unused items into quick cash and declutter your space.
22,710 articlesBiotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Nearly half of retirees lack a formal spending plan, risking decades of savings. A practical framework turns saved ye...
As market conditions shift in 2026, investors are weighing cheaper covered call ETFs against XYLD. Four funds stand o...
Oklo has zigzagged from a peak near $193 to much lower levels, raising questions about its momentum and prospects. Th...
At New Delhi's AI Impact Summit, a staged gesture exposed rivalries among top AI leaders, triggering a rethink of AI ...
C3.AI reports two consecutive quarterly revenue declines, forcing investors to reassess its enterprise AI strategy as...
Geopolitical tensions drive a risk-off market response as oil climbs and equities retreat, with investors weighing un...
Budget failure happens more often than you think. This expert guide breaks down the common reasons for budget failure...
A quartet of high-yield ETFs are now producing double-digit income in 2026, each using a different approach. Here's a...
A high-profile Arkansas event sparked financial ripples as sponsors and donors paused amid controversy. This article ...
Bright Horizons beats earnings estimates but unveils a larger-than-expected 2026 center-closure plan, sending bfam sh...
Rumble's Q4 2025 results point to a shift from rapid growth to sustainable profitability. This article breaks down re...